entertainment -WSS

entertainment

author：comprehensive 2025-09-05 07:02:52 - browse：8

Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability. Then, biotech veteran Michael Gilman calls in to offer a behind-the-scenes peek at what it’s like to be a startup CEO in this economic downturn — and which cocktail recipes help make it bearable. We also discuss a pioneering approval for a genome-editing medicine.

For more on what we cover, here’s the UnitedHealth story; here’s more on the CRISPR approval; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Menendez indictment could see pharma lose a key ally

WSS

CDC concerned about possible undetected monkeypox spread in U.K.

FDA seeks to regulate lab

Gene therapy has helped boys walk. Can scientists keep it that way?

With FDA staff opposed to Sarepta therapy, top official intervened

Shingles, which affected Dianne Feinstein, is on the rise

3 hurdles to bringing medical devices to the U.S. market

entertainment

entertainment

focus

Bright Health sells Medicare Advantage business to Molina

Why are elite athletes different? Take a look at their microbes

Trump demands the U.S. pay no more for drugs than other countries … again

Sudafed saga points to U.S. issues with evaluating older drugs

ChatGPT in medicine: STAT answers readers' burning questions

Menendez indictment could see pharma lose a key ally

DIEP, the 'gold standard' of breast reconstruction, is under threat

What would happen to your eyes if you looked at the solar eclipse?

Medical records are filled with copy

With FDA staff opposed to Sarepta therapy, top official intervened

hotspot

Why drug prescriptions should include diagnoses

Disclosing genetic information: not as worrisome as once feared

Colonoscopy at 40? Study finds a possible benefit

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Why we need to separate burnout from moral injury in health care

After a drawn out lobbying fight, ARPA

hotspot

Wikipedia

explore

focus